BRIEF-AMAG Gets FDA Approval Of Makena Subcutaneous Auto-Injector
February 14, 2018 at 18:24 PM EST
* AMAG PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF MAKENA® (HYDROXYPROGESTERONE CAPROATE INJECTION) SUBCUTANEOUS AUTO-INJECTOR TO REDUCE THE RISK OF PRETERM BIRTH IN CERTAIN AT-RISK WOMEN